BAXTER 25% GLUCOSE 250mg/L injection AHB0224

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:

glucose, Quantity: 250 g/L

Available from:

Baxter Healthcare Pty Ltd

INN (International Name):

glucose

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: water for injections

Administration route:

Intravenous

Units in package:

1000ml x 1

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

This product accepted for registration/listing as 'currently supplied' at the time of commencement of the Act. Indications held in ARTG paper records. (Old code)

Product summary:

Visual Identification: Clear slightly coloured solution; Container Type: Bag; Container Life Time: 18 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

1994-04-21

Patient Information leaflet

                                Page 1 of 2
GLUCOSE INTRAVENOUS INFUSION
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET?
This leaflet answers some
common questions about
Glucose 5%, 10%, 25%, 50%,
and 70% Intravenous Infusion
[‘Glucose IV Infusion’]. It does
not contain all of the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines have risks and
benefits. Your doctor has
weighed the risks of you being
given Glucose IV Infusion
against the benefits they expect
it will have for you.
IF YOU HAVE ANY CONCERNS
ABOUT THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET. You may
need to read it again.
WHAT GLUCOSE IV INFUSION
IS USED FOR
Glucose IV Infusion (5%) is
used for whenever non-
electrolyte fluid replacement is
required. It may also be used to
reconstitute and delivering other
drug products.
Glucose IV Infusion (≥10%) is
indicated as a source for energy
support, which can be used
alone or in combination with an
injectable nutrient supplement.
For example, in patients where:
(a) the gastrointestinal tract
cannot be used (such as, when
bowel rest is needed after
gastrointestinal surgery);
(b) the gastrointestinal
absorption of protein is
impaired; or
(c) metabolic requirements for
protein are substantially
increased (such as in the case
of extensive burns to the body).
BEFORE YOU ARE GIVEN
GLUCOSE IV INFUSION
_GLUCOSE IV INFUSION _(≥5%)
_SHOULD NOT BE GIVEN TO YOU IF: _
_ _

you have an allergy to corn
or corn products, or any
ingredient listed at the end
of this leaflet. Some of the
symptoms of an allergic
reaction may include skin
rash, itching or hives,
shortness of breath,
wheezing or difficulty
breathing, swelling of the
face, lips, tongue or other
parts of the body;

you already have too much
glucose in your blood;

you have had an ischaemic
stroke or head trauma
within 24 hours
Glucose IV Infusion (≥10%)
should also not be given if:

you are severely
dehydrated, or not passing
urine;

you are suffering from
bleeding in the brain or
spinal cor
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                BAXTER GLUCOSE INTRAVENOUS INFUSION
Version 1.2
1 of 16
AUSTRALIAN PRODUCT INFORMATION –
BAXTER GLUCOSE (GLUCOSE) INTRAVENOUS INFUSION
1
NAME OF THE MEDICINE
Glucose
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Baxter Glucose Intravenous (IV) Infusion preparations are sterile,
non-pyrogenic parenteral
solutions. They do not contain an antimicrobial agent or added buffer,
and have a pH of 3.5 -
6.5 for 5% to 25% Glucose concentrations, and a pH of 3.2 – 6.5 for
50% and 70% Glucose
concentrations. The concentrations of glucose dissolved in a litre of
Water for Injections and
their isotonicity are shown in Table 1 and 2 below:
TABLE 1: BAXTER GLUCOSE (5%) IV INFUSION PREPARATIONS (ISOTONIC)
CODE NO
.
ACTIVE COMPONENTS &
CONC. %(MMOL/1000ML);
ENERGY (KJ/L)
OSMOLARITY

(MOSMOL/L)
ARTG
PACK SIZE*
(ML)
AHB0062
Glucose 5 % (278); 835 kJ/L
278 (278)
48524
250 (1’s)
AHB0063
Glucose 5% (278); 835 kJ/L
278 (278)
48526
500 (1’s )
AHB0064
Glucose 5% (278); 835 kJ/L
278 (278)
48527
1000 (1’s)
AHB0086
Glucose 5% (278); 835 kJ/L
278 (278)
19503
50 (1’s)
AHB0093
Glucose 5% (278); 835 kJ/L
278 (278)
19503
50 (2’s)
AHB0087
Glucose 5% (278); 835 kJ/L
278 (278)
48525
100 (1’s)
AHB0094
Glucose 5% (278); 835 kJ/L
278 (278)
48525
100 (2’s)
Osmolarity

is calculated as glucose. The figures in the bracket are Osmolality
values in mOsmol/kg as printed
on the VIAFLEX bags. 1 gram of glucose provides 16.7 kiloJoules (kJ)
of energy
*Not all packs are marketed
TABLE 2: BAXTER GLUCOSE (10%, 25%, 50%, 70%) IV INFUSION PREPARATIONS
(HIGHLY
HYPERTONIC)
CODE NO
.
ACTIVE COMPONENTS &
CONC. % (MMOL/1000ML);
ENERGY (KJ/L)
OSMOLARITY

(MOSMOL/L)
ARTG
NO.
PACK SIZE*
(ML)
AHB0163
Glucose 10% (556); 1670 kJ/L
556 (556)
19480
500 (1’s)
AHB0164
Glucose 10% (556); 1670 kJ/L
556 (556)
48594
1000 (1’s)
AHB0224
Glucose 25% (1389); 4175 kJ/L
1389 (1390)
48521
1000 (1’s)
AHB0253
Glucose 50% (2778); 8350 kJ/L
2778 (2780)
19504
500 (1’s)
AHB0264**
Glucose 50% (2778);8350 kJ/L
2778 (2780)
48528
500 (1’s, filled
in 1L bag)
AHB0293
Gl
                                
                                Read the complete document